Literature DB >> 2565555

Oestrogen and progesterone sensitivity in cultured meningioma cells.

F Maiuri1, S Montagnani, B Gallicchio, M Carandente, G G Lanza, F D'Andrea.   

Abstract

Several studies have detected oestrogen and progesterone receptors in meningioma specimens; recently we have also confirmed the presence of steroid receptors in cultured cells from meningiomas. This paper describes the oestrogen and progesterone receptor assay in cultured cells from 6 meningiomas and the influence of steroid hormones on the cell growth and morphology. Four (66%) of the 6 specimens were positive for both receptors. Growth of cultured cells from tumours without receptors is not appreciably modified by the addition of hormones; the cultured cells from tumours with positive receptors are not essentially influenced by oestrogen, whereas progesterone produces a rapid and marked suppression of the cell growth and modifies their form and adhesivity; also the addition of an oestrogen and progesterone blend produces growth suppression. A similar effect of the progesterone on the cultured cells has also been obtained in a specimen of malignant meningioma. The results of this study suggest that the modulation of progesterone levels may be of therapeutic usefulness, particularly in patients with recurrent malignant meningiomas.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2565555     DOI: 10.1080/01616412.1989.11739853

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  9 in total

Review 1.  New prospects for management and treatment of inoperable and recurrent skull base meningiomas.

Authors:  Mahlon D Johnson; Burak Sade; Michael T Milano; Joung H Lee; Steven A Toms
Journal:  J Neurooncol       Date:  2007-07-12       Impact factor: 4.130

Review 2.  Orbital meningiomas: surgery, radiotherapy, or hormones?

Authors:  G E Rose
Journal:  Br J Ophthalmol       Date:  1993-05       Impact factor: 4.638

3.  Expression of estrogen receptors alpha and beta in human meningiomas.

Authors:  R S Carroll; J Zhang; P M Black
Journal:  J Neurooncol       Date:  1999-04       Impact factor: 4.130

Review 4.  The biology of meningiomas.

Authors:  I E McCutcheon
Journal:  J Neurooncol       Date:  1996-09       Impact factor: 4.130

Review 5.  Chemotherapy for meningiomas.

Authors:  A P Kyritsis
Journal:  J Neurooncol       Date:  1996-09       Impact factor: 4.130

6.  Double-Blind Phase III Randomized Trial of the Antiprogestin Agent Mifepristone in the Treatment of Unresectable Meningioma: SWOG S9005.

Authors:  Yongli Ji; Cathryn Rankin; Steven Grunberg; Andy E Sherrod; Jamshid Ahmadi; Jeannette J Townsend; Lynn G Feun; Ruth K Fredericks; Christy A Russell; Fairooz F Kabbinavar; Keith J Stelzer; Anne Schott; Claire Verschraegen
Journal:  J Clin Oncol       Date:  2015-11-02       Impact factor: 44.544

7.  Expression and localization of endothelin-1 and endothelin receptors in human meningiomas. Evidence for a role in tumoral growth.

Authors:  U Pagotto; T Arzberger; U Hopfner; J Sauer; U Renner; C J Newton; M Lange; E Uhl; A Weindl; G K Stalla
Journal:  J Clin Invest       Date:  1995-10       Impact factor: 14.808

8.  Progesterone-receptor index in meningiomas: correlation with clinico-pathological parameters and review of the literature.

Authors:  Stefan Wolfsberger; Soroush Doostkam; Hans-Gerd Boecher-Schwarz; Karl Roessler; Michael van Trotsenburg; Johannes A Hainfellner; Engelbert Knosp
Journal:  Neurosurg Rev       Date:  2004-05-27       Impact factor: 3.042

9.  Meningiomas in Premenopausal Women: Role of the Hormone Related Conditions.

Authors:  Francesco Maiuri; Giuseppe Mariniello; Teresa Somma; Elia Guadagno; Sergio Corvino; Serena Pagano; Valentina Orlando; Marialaura Del Basso De Caro
Journal:  Front Oncol       Date:  2020-12-11       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.